Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons

Journal of Neuroscience

Volumn 31, Issue 4, 2011, Pages 1375-1385

  Cadaveira Mosquera, Alba ^a   Ribeiro, Sandro J ^a   Reboreda, Antonio ^a   Pérez, Montse ^a   Lamas, J Antonio ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BARIUM; FLUOXETINE; LINOLEIC ACID; MESSENGER RNA; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN; QUININE; RILUZOLE; TREK1 PROTEIN; TREK2 PROTEIN; UNCLASSIFIED DRUG; ZINC;

ACIDIFICATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CERVICAL GANGLION; CONTROLLED STUDY; EXCITABILITY; EXPERIMENT; FLOW; GANGLION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAMMAL; MEMBRANE POTENTIAL; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE; SYMPATHETIC NERVE CELL; WHOLE CELL;

ACTION POTENTIALS; ANIMALS; CELLS, CULTURED; MEMBRANE POTENTIALS; MICE; NEURONS; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RILUZOLE; RNA, MESSENGER; SUPERIOR CERVICAL GANGLION;

EID: 79251563134     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2791-10.2011     Document Type: Article

References (67)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403-410.
2. + channel family. J Biol Chem 275:17412-17419.
3. Brown DA, Constanti A (1980) Intracellular observations on the effects of muscarinic agonists on rat sympathetic neurones. Br J Pharmacol 70:593-608.
4. Brown DA, Adams PR, Constanti A (1982) Voltage-sensitive K-currents in sympathetic neurons and their modulation by neurotransmitters. J Auton Nerv Syst 6:23-35.
5. Buckler KJ, Vaughan-Jones RD (1998) Effects of mitochondrial uncouplers on intracellular calcium, pH and membrane potential in rat carotid body type I cells. J Physiol 513:819-833.
6. Bushell T, Clarke C, Mathie A, Robertson B (2002) Pharmacological characterization of a non-inactivating outward current observed in mouse cerebellar Purkinje neurones. Br J Pharmacol 135:705-712.
7. SO, by zinc. J Physiol 560:51-62.
8. Czirják G, Enyedi P (2002) Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J Biol Chem 277:5426-5432.
9. + channels. Mol Pharmacol 69:1024-1032.
10. + channels by polyunsaturated fatty acids and lysophospholipids. J Membr Biol 195:147-164.
11. + channels. Neuron 63:230-243.
12. + channels TREK-1 and TRAAK. Mol Pharmacol 57:906-912.
13. + channel in adrenocortical cells is TREK-1. J Biol Chem 277:49186-49199.
14. + channel. EMBO J 15:6854-6862.
15. + channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J 17:3297-3308.
16. Grunnet M, Jespersen T, Angelo K, Frøkjaer-Jensen C, Klaerke DA, Olesen SP, Jensen BS (2001) Pharmacological modulation of SK3 channels. Neuropharmacology 40:879-887.
17. Hadley JK, Passmore GM, Tatulian L, Al-Qatari M, Ye F, Wickenden AD, Brown DA (2003) Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic Mchannels deduced from block by tetraethylammonium. J Neurosci 23:5012-5019.
18. Hahn SJ, Choi JS, Rhie DJ, Oh CS, Jo YH, Kim MS (1999) Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells. Eur J Pharmacol 367:113-118.
19. Han J, Truell J, Gnatenco C, Kim D (2002) Characterization of four types of background potassium channels in rat cerebellar granule neurons. J Physiol 542:431-444.
20. Han J, Gnatenco C, Sladek CD, Kim D (2003) Background and tandem-pore potassium channels in magnocellular neurosecretory cells of the rat supraoptic nucleus. J Physiol 546:625-639.
21. Hebert T, Drapeau P, Pradier L, Dunn RJ (1994) Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol Pharmacol 45:1055-1060.
22. Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M (2006) Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9:1134-1141.
23. Huang CS, Song JH, Nagata K, Yeh JZ, Narahashi T (1997) Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J Pharmacol Exp Ther 282:1280-1290. (Pubitemid 27408305)
24. Imai S, Suzuki T, Sato K, Tokimasa T (1999) Effects of quinine on three different types of potassium currents in bullfrog sympathetic neurons. Neurosci Lett 275:121-124.
25. + channels in dorsal root ganglion neurons. Am J Physiol Cell Physiol 291:C138-C146.
26. Kang D, Choe C, Kim D (2004) Functional expression of TREK-2 in insulin-secreting MIN6 cells. Biochem Biophys Res Commun 323:323-331. (Pubitemid 39200685)
27. Kang D, Han J, Kim D (2006) Mechanism of inhibition of TREK-2 (K2P10.1) by the Gq-coupled M3 muscarinic receptor. Am J Physiol Cell Physiol 291:C649-C656.
28. Kang D, Kim GT, Kim EJ, La JH, Lee JS, Lee ES, Park JY, Hong SG, Han J (2008) Lamotrigine inhibits TRESK regulated by G-protein coupled receptor agonists. Biochem Biophys Res Commun 367:609-615.
29. Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL, Mathie A (2005) Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol 144:821-829.
30. Kim JS, Park JY, Kang HW, Lee EJ, Bang H, Lee JH (2005) Zinc activates TREK-2 potassium channel activity. J Pharmacol Exp Ther 314:618-625.
31. Kucheryavykh LY, Kucheryavykh YV, Inyushin M, Shuba YM, Sanabria P, Cubano LA, Skatchkov SN, Eaton MJ (2009) Ischemia increases TREK-2 channel expression in astrocytes: relevance to glutamate clearance. Open Neurosci J 3:40-47.
32. h) contributes to resting membrane potential in rat superior cervical sympathetic neurones. Pflugers Arch 436:429-435.
33. Lamas JA, Reboreda A, Codesido V (2002) Ionic basis of the resting membrane potential in cultured rat sympathetic neurons. Neuroreport 13:585-591.
34. Lamas JA, Romero M, Reboreda A, Sánchez E, Ribeiro SJ (2009) A riluzoleand valproate-sensitive persistent sodium current contributes to the resting membrane potential and increases the excitability of sympathetic neurones. Pflugers Arch 458:589-599.
35. + channel with a novel structure. EMBO J 15:1004-1011.
36. + channel. FEBS Lett 471:137-140.
37. + channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. J Biol Chem 275:28398-28405.
38. Li ZB, Zhang HX, Li LL, Wang XL (2005) Enhanced expressions of arachidonic acid-sensitive tandem-pore domain potassium channels in rat experimental acute cerebral ischemia. Biochem Biophys Res Commun 327:1163-1169.
39. + channels. Cell Biochem Biophys 47:209-256.
40. Magistretti J, Mantegazza M, de Curtis M, Wanke E (1998) Modalities of distortion of physiological voltage signals by patch-clamp amplifiers: a modeling study. Biophys J 74:831-842.
41. + channel. J Biol Chem 274:1381-1387.
42. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honoré E (1999b) Mechanoor acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem 274:26691-26696.
43. + channels TREK-1 and TRAAK. J Biol Chem 275:10128-10133.
44. + channel. EMBO J 19:2483-2491.
45. Martínez-Pinna J, Lamas JA, Gallego R (2002) Calcium current components in intact and dissociated adult mouse sympathetic neurons. Brain Res 951:227-236.
46. Mathie A, Veale EL (2007) Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Curr Opin Investig Drugs 8:555-562.
47. Meadows HJ, Benham CD, Cairns W, Gloger I, Jennings C, Medhurst AD, Murdock P, Chapman CG (2000) Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel. Pflugers Arch 439:714-722.
48. + channels TREK-1 and TRAAK. Brain Res 892:94-101.
49. Neher E (1992) Correction for liquid junction potentials in patch clamp experiments. Methods Enzymol 207:123-131.
50. + channel gene KCNK4: chromosomal localization, tissue distribution and functional expression. Mol Brain Res 102:18-27.
51. + channels. Trends Neurosci 24:339-346.
52. + channel. EMBO J 17:4283-4290.
53. Rae J, Cooper K, Gates P, Watsky M (1991) Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37:15-26.
54. Reboreda A, Sánchez E, Romero M, Lamas JA (2003) Intrinsic spontaneous activity and subthreshold oscillations in neurones of the rat dorsal column nuclei in culture. J Physiol 551:191-205. (Pubitemid 37062922)
55. + channel from human kidney. J Biol Chem 273:30863-30869.
56. Reyes R, Lauritzen I, Lesage F, Ettaiche M, Fosset M, Lazdunski M (2000) Immunolocalization of the arachidonic acid and mechanosensitive baseline TRAAK potassium channel in the nervous system. Neuroscience 95:893-901.
57. Robbins J, Trouslard J, Marsh SJ, Brown DA (1992) Kinetic and pharmacological properties of the M-current in rodent neuroblastoma X glioma hybrid cells. J Physiol 451:159-185.
58. Romero M, Reboreda A, Sánchez E, Lamas JA (2004) Newly developed blockers of the M-current do not reduce spike frequency adaptation in cultured mouse sympathetic neurons. Eur J Neurosci 19:2693-2702. (Pubitemid 38746386)
59. Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics methods and protocols: methods in molecular biology (Krawetz S, Misener S, eds), pp 365-386. Totowa, NJ: Humana.
60. Suh BC, Hille B (2002) Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35:507-520.
61. + channel, is modulated by multiple neurotransmitters in motoneurons. Neuron 25:399-410.
62. Talley EM, Solorzano G, Lei Q, Kim D, Bayliss DA (2001) CNS distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci 21:7491-7505. (Pubitemid 32904948)
63. Ca channels in cultured differentiated human skeletal muscle cells. Life Sci 82:11-20.
64. Winks JS, Hughes S, Filippov AK, Tatulian L, Abogadie FC, Brown DA, Marsh SJ (2005) Relationship between membrane phosphatidylinositol 4,5-bisphosphate and receptor-mediated inhibition of native neuronal M channels. J Neurosci 25:3400-3413. (Pubitemid 40471348)
65. Yamamoto Y, Hatakeyama T, Taniguchi K (2009) Immunohistochemical colocalization of TREK-1, TREK-2 and TRAAK with TRP channels in the trigeminal ganglion cells. Neurosci Lett 454:129-133.
66. Yang SB, Jan LY (2008) Thrilling moment of an inhibitory channel. Neuron 58:823-824.
67. v potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol 128:1609-1615.